These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6168859)

  • 1. Electrophysiologic and antiarrhythmic effects of nitroglycerin in man.
    Hoelzer M; Schaal SF; Leier CV
    J Cardiovasc Pharmacol; 1981; 3(5):917-23. PubMed ID: 6168859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic properties of flecainide acetate.
    Estes NA; Garan H; Ruskin JN
    Am J Cardiol; 1984 Feb; 53(5):26B-29B. PubMed ID: 6695816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion.
    Levites R; Bodenheimer MM; Helfant RH
    Circulation; 1975 Dec; 52(6):1050-5. PubMed ID: 810264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic properties of falipamil (AQA-39)--a new bradycardiac agent.
    Lévy S; Mètge M; Hilaire J; Cointe R; Bru P; Eychenne JL; Gérard R
    Eur Heart J; 1987 Nov; 8(11):1236-40. PubMed ID: 3691560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agent.
    Greene HL; Werner JA; Gross BW; Sears GK; Trobaugh GB; Cobb LA
    Am Heart J; 1983 Sep; 106(3):492-501. PubMed ID: 6881021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nitroglycerin on atrioventricular conduction in man.
    Gould L; Reddy DV; Chua W; Swamy CR; Dorismond JC
    Am J Med; 1976 May; 60(6):922-7. PubMed ID: 828458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of effects of nitroglycerin on regional refractoriness and regional myocardial blood flow following acute coronary occlusion.
    Michaelson SP; Batsford WP; Zaret BL
    Cardiovasc Res; 1979 Jul; 13(7):407-12. PubMed ID: 114301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiology of atropine.
    Bissett JK; de Soyza ND; Kane JJ; Murphy ML
    Cardiovasc Res; 1975 Jan; 9(1):73-80. PubMed ID: 804352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of OPC-88117, a new antiarrhythmic agent, on the electrophysiological properties of rabbit isolated hearts.
    Nezasa Y; Kodama I; Toyama J
    Br J Pharmacol; 1989 Sep; 98(1):186-91. PubMed ID: 2553187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of sotalol on the immature mammalian heart.
    Houyel L; Fournier A; Ducharme G; Chartrand C; Davignon A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):134-9. PubMed ID: 1375680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute changes in infranodal conduction time following left ventriculography and sublingual nitroglycerin administration in man.
    Peters RW; Fisher ML; Resnick S; Plotnick GD; Carliner NH; Scheinman MM
    Am Heart J; 1983 Sep; 106(3):464-70. PubMed ID: 6410892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac electrophysiologic effects of fentanyl and combinations of fentanyl and neuromuscular relaxants in pentobarbital-anesthetized dogs.
    Royster RL; Keeler DK; Haisty WK; Johnston WE; Prough DS
    Anesth Analg; 1988 Jan; 67(1):15-20. PubMed ID: 3337342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine.
    Villafane J; Gelband H; Xu H; McCormack J; Stolfi A; Pickoff AS
    Pediatr Res; 1987 Jul; 22(1):50-4. PubMed ID: 3627871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
    Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.